This study is testing a new medicine called **NNC0487-0111** to see how well it lowers blood sugar and body weight for people with type 2 diabetes. Type 2 diabetes is when your body can't use sugar properly, causing high blood sugar levels. The medicine is given as tablets or injections, but it's not available from doctors yet. You'll either receive the medicine or a placebo (a dummy pill) by chance. The study takes about 43 weeks.
To join, you must be between 18-75 years old, have had type 2 diabetes for at least 180 days, and be on stable diabetes medication like metformin. Your blood sugar level (HbA1c) must be between 7.0-10.0%. You must also agree to wear a special device to monitor your blood sugar.
You can't join if you are on other diabetes or obesity medications, have eye problems from diabetes, or don't notice when your blood sugar is too low.
- The study lasts for about 43 weeks.
- You will receive either the new medicine or a placebo.
- Participants must wear a continuous glucose monitoring device.